NCT01623895View on ClinicalTrials.gov

Pharmacogenetic Study in Patients Received Iron Chelating Agent

CompletedOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

December 31, 2007

Primary Completion Date

June 30, 2013

Study Completion Date

June 30, 2013

Conditions
Hemosiderosis
Trial Locations (1)

Unknown

Seoul National University Hospital, Seoul

All Listed Sponsors
lead

Seoul National University Hospital

OTHER

NCT01623895 - Pharmacogenetic Study in Patients Received Iron Chelating Agent | Biotech Hunter | Biotech Hunter